Jundishapur Journal of Microbiology

Published by: Kowsar

Etiological Diagnosis of Community-Acquired Pneumonia in Adult Patients: A Prospective Hospital-Based Study in Mashhad, Iran

Hamidreza Naderi 1 , Fereshte Sheybani 1 , * , Mohammadreza Sarvghad 1 , Zahra Meshkat 2 and Mehdi Jabbari Nooghabi 3
Authors Information
1 Department of Infectious Diseases, Imam Reza Teaching Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Clinical Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Statistics, Faculty of Mathematics, Ferdowsi University, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2015, 8 (8); e22780
  • Published Online: August 29, 2015
  • Article Type: Research Article
  • Received: August 14, 2014
  • Revised: October 22, 2014
  • Accepted: November 10, 2014
  • DOI: 10.5812/jjm.22780

To Cite: Naderi H, Sheybani F, Sarvghad M, Meshkat Z, Jabbari Nooghabi M. Etiological Diagnosis of Community-Acquired Pneumonia in Adult Patients: A Prospective Hospital-Based Study in Mashhad, Iran, Jundishapur J Microbiol. 2015 ; 8(8):e22780. doi: 10.5812/jjm.22780.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 2010;
  • 2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524): 1747-57[DOI]
  • 3. File TJ, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010; 122(2): 130-41[DOI][PubMed]
  • 4. Marrie TJ, Basow DS, Waltham MA. 2012;
  • 5. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44-72
  • 6. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011; 52 Suppl 4-304[DOI][PubMed]
  • 7. Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection. 2000; 28(2): 68-73[PubMed]
  • 8. Berg P, Lindhardt BO. The role of procalcitonin in adult patients with community-acquired pneumonia--a systematic review. Dan Med J. 2012; 59(3)[PubMed]
  • 9. Benenson RS, Kepner AM, Pyle D2, Cavanaugh S. Selective use of blood cultures in emergency department pneumonia patients. J Emerg Med. 2007; 33(1): 1-8[DOI][PubMed]
  • 10. Ishida T, Hashimoto T, Arita M, Ito I, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest. 1998; 114(6): 1588-93[PubMed]
  • 11. Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000; 31(4): 869-74[DOI][PubMed]
  • 12. Sorde R, Falco V, Lowak M, Domingo E, Ferrer A, Burgos J, et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med. 2011; 171(2): 166-72[DOI][PubMed]
  • 13. Alavi SM, Moshiri N, Moosavian M, Yusefi F, Abbasi E. Seroprevalence of Legionella pneumophila in admitted patients with pneumonia in training hospitals, Ahvaz, Iran (2007-2008). Pak J Med Sci. 2009; 25(5): 811-6
  • 14. Fard SY, Nomanpour B, Fatolahzadeh B, Mobarez AM, Darban-Sarokhalil D, Fooladi AA, et al. Hospital acquired pneumonia: comparison of culture and real-time PCR assays for detection of Legionella pneumophila from respiratory specimens at Tehran hospitals. Acta Microbiol Immunol Hung. 2012; 59(3): 355-65[DOI][PubMed]
  • 15. Bagheri Lankarani K, Vodjdani R, Khozaii A, Beheshti M, Oboodi B, Alborzi A, et al. Legionella pneumophillia In Southern Iran. Shiraz E-Med J. 2004; 5(1)
  • 16. Hajia M, Hossieni-Doust R, Rahbar M. Identification of Legionella Pneumophila in Bronchoalveolar Lavage Fluid Specimens by PCR. Arch Iran Med. 2004; 7(4): 287-91
  • 17. Mirkalantari S, Mohabati Mobarez A, Hoseini Dost SR, Aslani J. Isolation of Legionella from BAL samples of Legionella pneumonia patients, by PCR and Culture Methods. Modares j Med Sci: Pathobiology. 2008; 10: 75-83
  • 18. Nomanpour B, Ghodousi A, Babaei T, Jafari S, Feizabadi MM. Single tube real time PCR for detection of Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila from clinical samples of CAP. Acta Microbiol Immunol Hung. 2012; 59(2): 171-84[DOI][PubMed]
  • 19. Chamani-Tabriz L, Jeddi-Tehrani M, Motahari S, Zeraati H, Asgari S, Karegar M, et al. Detection of Legionella pneumophila by nested PCR-RFLP and ELISA on urine specimens of pregnant women with respiratory infections. . 2007; 8(3):221-229. Med J Reprod Infertil. 2007; 8(3): 221-9
  • 20. Moosavian M, Dashti A. Isolation and identification of legionellosis agents from fishponds, swimming pools and cooling towers in Khuzestan province, Iran. . Jundishapur J.Microbiol. 2011; 4(4): 209-16
  • 21. Ghotaslou R, Yeganeh Sefidan F, Akhi MT, Soroush MH, Hejazi MS. Detection of legionella contamination in tabriz hospitals by PCR assay. Adv Pharm Bull. 2013; 3(1): 131-4[DOI][PubMed]
  • 22. Ajami B, Ghazvini K, Movahhed T, Ariaee N, Shakeri M, Makarem S. Contamination of a dental unit water line system by legionella pneumophila in the mashhad school of dentistry in 2009. Iran Red Crescent Med J. 2012; 14(6): 376-8[PubMed]
  • 23. Den Boer JW, Nijhof J, Friesema I. Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study. Public Health. 2006; 120(6): 566-71[DOI][PubMed]
  • 24. Ricketts KD, Joseph CA, European Working Group for Legionella I. Legionnaires disease in Europe: 2005-2006. Euro Surveill. 2007; 12(12)-8[PubMed]
  • 25. Ishida T. [Etiology of community-acquired pneumonia among adult patients in Japan]. Jpn J Antibiot. 2000; 53 Suppl B: 3-12[PubMed]
  • 26. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Kleemola M, Koskela M, et al. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis. 2001; 32(8): 1141-54[DOI][PubMed]
  • 27. Hashemi SH, Soozanchi G, Jamal-Omidi S, Yousefi-Mashouf R, Mamani M, Seif-Rabiei MA. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults. Trop Doct. 2010; 40(2): 89-91[DOI][PubMed]
  • 28. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996; 275(2): 134-41[PubMed]
  • 29. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009; 64(12): 1062-9[DOI][PubMed]
  • 30. Garcia-Vidal C, Calbo E, Pascual V, Ferrer C, Quintana S, Garau J. Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J. 2007; 30(5): 951-6[DOI][PubMed]
  • 31. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279(18): 1452-7[PubMed]
  • 32. Menendez R, Torres A, Rodriguez de Castro F, Zalacain R, Aspa J, Martin Villasclaras JJ, et al. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 2004; 39(12): 1783-90[DOI][PubMed]
  • 33. Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008; 47(3): 375-84[DOI][PubMed]
  • 34. Davis JS, Cross GB, Charles PG, Currie BJ, Anstey NM, Cheng AC. Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Med J Aust. 2010; 192(3): 133-6[PubMed]
  • 35. Robins-Browne KL, Cheng AC, Thomas KA, Palmer DJ, Currie BJ, Davis JS. The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study. Trop Med Int Health. 2012; 17(7): 914-9[DOI][PubMed]
  • 36. Marras TK, Gutierrez C, Chan CK. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest. 2000; 118(5): 1339-43[PubMed]
  • 37. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002; 165(6): 766-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments